Controversial Vaccine Preservative to be Discussed Tomorrow at CDC Meeting

|

vaccineAtlanta, GA -- The Advisory Committee on Immunization Practices (ACIP) will meet tomorrow at the CDC in Atlanta. Thimerosal, a controversial mercury- based vaccine preservative still used in flu shots, will be discussed. Health Reporters are encouraged to attend. Lyn Redwood of the National Autism Association and the Coalition for SafeMinds will be in attendance and available to speak with members of the press.

WHAT:
The Advisory Committee on Immunization Practices (ACIP) Meeting

WHEN:
Tomorrow, February 21st and Thursday, February 22nd from 7:00a.m.-6:00p.m.
Ethylmercury Thimerosal is scheduled to be discussed tomorrow at 10:55 am. 

WHERE:
CDC, Building 19, Room 232
Visitor Entry Point: Visitor's Center
CDC Contact: Dee Gardner, 404-639-8836, DGardner@cdc.gov
Meeting Contact: Judy Rayburn, Building 19

ADDRESS:
Centers for Disease Control and Prevention
1600 Clifton Road, NE
Building 19, Room 232, Auditorium B
Atlanta, Georgia 30333

MEETING AGENDA:
http://www.cdc.gov/nip/ACIP/agendas.htm

REGISTRATION:
Register online at http://www2.cdc.gov/nip/ACIP/februaryRegistration.asp

To learn more about autism, please visit www.nationalautism.org.


CONTACT: Lyn Redwood, Atlanta, GA, +1-404-932-1786, or Rita Shreffler, Nixa, MO, +1-417-725-9544, or Wendy Fournier, Portsmouth, RI, +1-401-632-7523, all of the National Autism Association.